Published in Medical Device Law Weekly, May 29th, 2005
The clinical study, which was approved by the Royal Brisbane & Women's Hospital human research ethics committee, is being conducted under the Australian Therapeutic Goods Administration (TGA) Clinical Trial Notification Scheme.
Epi-LASIK is the next generation in laser vision correction (LVC). It combines the benefits of current LVC procedures and eliminates their disadvantages, particularly the need to cut the eye, according to Norwood.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly